Your browser doesn't support javascript.
Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in England.
Møller Kirsebom, Freja Cordelia; Andrews, Nick; Stowe, Julia; Groves, Natalie; Chand, Meera; Ramsay, Mary; Bernal, Jamie Lopez.
  • Møller Kirsebom FC; UK Health Security Agency, London, United Kingdom.
  • Andrews N; UK Health Security Agency, London, United Kingdom.
  • Stowe J; NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Groves N; UK Health Security Agency, London, United Kingdom.
  • Chand M; UK Health Security Agency, London, United Kingdom.
  • Ramsay M; UK Health Security Agency, London, United Kingdom.
  • Bernal JL; Guys and St Thomas's Hospital NHS Trust, London, United Kingdom.
Lancet Reg Health Eur ; 23: 100537, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2105528
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies Topics: Vaccines / Variants Language: English Journal: Lancet Reg Health Eur Year: 2022 Document Type: Article Affiliation country: J.lanepe.2022.100537

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies Topics: Vaccines / Variants Language: English Journal: Lancet Reg Health Eur Year: 2022 Document Type: Article Affiliation country: J.lanepe.2022.100537